Jubilant Pharmova Limited Total Liabilities

Latest as of September 2025: Rs69.50 Billion INR ≈ $751.56 Million USD

Jubilant Pharmova Limited total liabilities. Based on the latest financial reports, Jubilant Pharmova Limited (JUBLPHARMA) has total liabilities worth Rs69.50 Billion INR (≈ $751.56 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Jubilant Pharmova Limited liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Jubilant Pharmova Limited (2004–2025)

Total liabilities of Jubilant Pharmova Limited from 2004 to 2025. This chart illustrates how Jubilant Pharmova Limited's total liabilities have evolved over time, based on quarterly financial data.

Jubilant Pharmova Limited Competitors by Total Liabilities

The table below lists competitors of Jubilant Pharmova Limited ranked by their total liabilities.

Company	Country	Total Liabilities
Nantong Haixing Electronics Co Ltd SHG:603115	China	CN¥1.14 Billion
Shenzhen China Micro Semicon Co. Ltd. A SHG:688380	China	CN¥304.00 Million
Tangshan Sanyou Chemical Industries Co Ltd SHG:600409	China	CN¥11.24 Billion
Bayer Cropscience Limited NSE:BAYERCROP	India	Rs-29.66 Billion
Beijing New Oriental Star Petrochemical Engineering Co Ltd SHE:002755	China	CN¥1.16 Billion
GigaCloud Technology Inc Class A Ordinary Shares NASDAQ:GCT	USA	$716.66 Million
JiangXi Tianxin Pharm Co Ltd SHG:603235	China	CN¥1.19 Billion
Westone Information Industry Inc SHE:002268	China	CN¥1.59 Billion

Liability Composition Analysis (2004–2025)

This chart breaks down Jubilant Pharmova Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see how large is Jubilant Pharmova Limited's balance sheet.

Liquidity & Leverage Metrics

Jubilant Pharmova Limited Total Liabilities Ratios Explained

Jubilant Pharmova Limited total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	1.66	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	1.05	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.51	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Jubilant Pharmova Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Jubilant Pharmova Limited (2004–2025)

The table below shows the annual total liabilities of Jubilant Pharmova Limited from 2004 to 2025.

Year	Total Liabilities	Change
2025-03-31	Rs65.18 Billion ≈ $704.88 Million	+6.37%
2024-03-31	Rs61.27 Billion ≈ $662.66 Million	+6.29%
2023-03-31	Rs57.65 Billion ≈ $623.45 Million	+23.33%
2022-03-31	Rs46.74 Billion ≈ $505.53 Million	+11.92%
2021-03-31	Rs41.77 Billion ≈ $451.68 Million	-39.63%
2020-03-31	Rs69.18 Billion ≈ $748.13 Million	+3.88%
2019-03-31	Rs66.59 Billion ≈ $720.20 Million	+19.29%
2018-03-31	Rs55.83 Billion ≈ $603.74 Million	-1.09%
2017-03-31	Rs56.44 Billion ≈ $610.37 Million	-6.52%
2016-03-31	Rs60.37 Billion ≈ $652.93 Million	-2.29%
2015-03-31	Rs61.79 Billion ≈ $668.20 Million	+1.69%
2014-03-31	Rs60.76 Billion ≈ $657.11 Million	+4.29%
2013-03-31	Rs58.26 Billion ≈ $630.07 Million	+6.96%
2012-03-31	Rs54.47 Billion ≈ $589.09 Million	+1.82%
2011-03-31	Rs53.50 Billion ≈ $578.56 Million	+16.67%
2010-03-31	Rs45.85 Billion ≈ $495.88 Million	-14.07%
2009-03-31	Rs53.36 Billion ≈ $577.07 Million	+80.69%
2008-03-31	Rs29.53 Billion ≈ $319.38 Million	+26.36%
2007-03-31	Rs23.37 Billion ≈ $252.75 Million	+93.04%
2006-03-31	Rs12.11 Billion ≈ $130.93 Million	+59.66%
2005-03-31	Rs7.58 Billion ≈ $82.00 Million	+14.92%
2004-03-31	Rs6.60 Billion ≈ $71.36 Million	--

About Jubilant Pharmova Limited

NSE:JUBLPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$1.58 Billion

Rs146.32 Billion INR

Market Cap Rank

#6739 Global

#313 in India

Share Price

Rs923.80

Change (1 day)

-2.35%

52-Week Range

Rs807.65 - Rs1181.20

All Time High

Rs1269.00